Literature DB >> 29389391

REPRISE: tolvaptan in advanced polycystic kidney disease.

Christina M Wyatt1, Yannick Le Meur2.   

Abstract

Entities:  

Keywords:  ADPKD; chronic kidney disease; vasopressin

Mesh：

Substances：

Year:  2018        PMID： 29389391     DOI： 10.1016/j.kint.2017.12.002

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  3 in total

Review 1.  Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Hannah A Blair
Journal:  Drugs       Date:  2019-02       Impact factor: 9.546

Review 2.  Is serum copeptin a modifiable biomarker in autosomal dominant polycystic kidney disease?

Authors:  Moomal Tasneem; Carly Mannix; Annette Wong; Jennifer Zhang; Gopala Rangan
Journal:  World J Nephrol       Date:  2018-03-06

Review 3.  Recent advances in the clinical management of autosomal dominant polycystic kidney disease.

Authors:  Roser Torra
Journal:  F1000Res       Date:  2019-01-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.